Septimiu Murgu to Adenocarcinoma
This is a "connection" page, showing publications Septimiu Murgu has written about Adenocarcinoma.
Connection Strength
0.122
-
Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation. Oncotarget. 2016 Apr 05; 7(14):18876-86.
Score: 0.079
-
Bronchoscopy for bevacizumab-related hemoptysis. Lung Cancer. 2007 Jun; 56(3):465-8.
Score: 0.043